Test Strip Market Regional Analysis

Global Test Strip Market size was valued at USD 5.5 billion in 2023 and is poised to grow from USD 6.02 billion in 2024 to USD 12.45 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The Global Test Strip market is consolidated in nature, with a limited number of players operating in the market. These industry leaders are focusing on developing strategies that would help them in their sustainable growth. Companies are focusing on investments in research and development field for a maximum market share. Companies are experimenting with solutions in underdeveloped countries and remote areas. 'Abbott Laboratories (USA) ', 'Acon Laboratories (USA) ', 'Arkray (Japan) ', 'B. Braun (Germany) ', 'Lifescan (USA) ', 'Roche (Switzerland) ', 'Siemens Healthineers (Germany) ', 'Tiadoc Technology (China) ', 'Teco Diagnostics (USA) ', 'Becton, Dickinson and Company (USA) ', 'Johnson & Johnson (USA) ', 'Bio-Rad Laboratories (USA) ', 'BioMerieux (France) ', 'Chembio Diagnostic Systems (USA) ', 'Nipro Corporation (Japan) ', 'PTS Diagnostics (USA) ', 'Quidel Corporation (USA) ', 'Trinity Biotech (Ireland) ', 'Wondfo Biotech (China)'

The growing cost of blood glucose test strips has received a lot of attention (BGTS). Insulin users have traditionally been classified as a single homogenous group, leading in regulations that limit consumption (8.2 strips/day) in provincial prescription insurance systems. 

Increase in prevalence of diabetes: In the forecast period, the diabetes segment is expected to dominate the market. Diabetes tests are becoming more common as the prevalence and incidence of diabetes rise internationally, which is likely to boost the segment's growth throughout the forecast period. Diabetes test strips are a practical approach for diabetic people to monitor blood sugar levels, often known as glucose levels. This is particularly important for diabetics. Glucose meters are used to read blood sugar levels on the strips.

Asia Pacific is predicted to increase at a 5.7% annual rate over the projection period. China has the most diabetes sufferers worldwide, followed by India. As a result, the increased prevalence of diabetes in Asian countries would increase product demand, boosting business growth. Increased alcohol consumption, along with a lack of physical activity, will contribute to an increase in diabetes prevalence. Furthermore, the rising prevalence of obesity in these nations is a key factor leading to the rise of diabetes, consequently raising market revenue. Furthermore, the North American test strips market is predicted to be significant in 2022, owing to an increase in the number of firms manufacturing diabetes test strips in the United States.